Literature DB >> 82607

Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats.

R S Fujinami, P Y Paterson, E D Day, V A Varitek.   

Abstract

Age-related concentrations of myelin basic protein serum factor (MBP-SF), an endogenous neuroantigen detected and quantitated by inhibition of binding of rat myelin basic protein (RMBP) antibody with 125I-RMBP reagent antigen and immunochemically indistinguishable from native RMBP in this respect, reach peak levels as high as 21 ng/microliter among 2-3-wk-old normal suckling Lewis rats. Levels then progressively decline to low, usually undetectable levels of less than or equal to 0.6 ng/microliter MBP-equivalents in adult animals by 7 wk of age. MBP-SF levels are inversely related to the age-related increasing capacity of maturing Lewis rats to develop experimental allergic encephalomyelitis (EAE) after sensitization to MBP of syngeneic, but not xenogeneic, origin. MBP-SF appears to be an endogenous neuroimmunoregulatory product of potential importance for immunologic tolerance to autologous RMBP in Lewis rats.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82607      PMCID: PMC2185114          DOI: 10.1084/jem.148.6.1716

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

Review 1.  Immunological unresponsiveness.

Authors:  W O Weigle
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

2.  Myelin basic protein serum factor (MBP-SF) in adult Lewis rats: a method for detection and evidence that MBP-SF influences the appearance of antibody to MBP in animals developing experimental allergic encephalomyelitis.

Authors:  E D Day; V A Varitek; P Y Paterson
Journal:  Immunochemistry       Date:  1978-07

3.  Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen.

Authors:  L Steinman; I R Cohen; D Teitelbaum; R Arnon
Journal:  Nature       Date:  1977-01-13       Impact factor: 49.962

4.  Induction of experimental allergic encephalomyelitis in suckling Lewis rats: role of age and type of sensitizing neuroantigen.

Authors:  R S Fujinami; P Y Paterson
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

5.  Experimental allergic encephalomyelitis in suckling Lewis rats: comparison with the disease in adult animals.

Authors:  M C Dal Canto; R S Fujinami; P Y Paterson
Journal:  Lab Invest       Date:  1977-10       Impact factor: 5.662

6.  The extensive cross-reaction of several syngeneic rat-anti-BP antiserums with myelin basic proteins (BP) of other species.

Authors:  O M Pitts; V A Varitek; E D Day
Journal:  Immunochemistry       Date:  1976-04

7.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

Authors:  G E Deibler; R E Martenson; M W Kies
Journal:  Prep Biochem       Date:  1972

8.  Autoimmune encephalomyelitis: activation of thymus lymphocytes against syngeneic brain antigens in vitro.

Authors:  S Orgad; I R Cohen
Journal:  Science       Date:  1974-03-15       Impact factor: 47.728

9.  Regulation of autosensitization. The immune activation and specific inhibition of self-recognizing thymus-derived lymphocytes.

Authors:  I R Cohen; H Wekerle
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Suppression of allergic encephalomyelitis in rats by means of antibrain serum.

Authors:  P Y PATERSON; S M HARWIN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

View more
  3 in total

1.  Alloreactive immune responses of transgenic mice expressing a foreign transplantation antigen in a soluble form.

Authors:  B Arnold; O Dill; G Küblbeck; L Jatsch; M M Simon; J Tucker; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

2.  Cellular cytotoxicity and gastrointestinal inflammation in inbred rats: induction with gut organ-specific antigens.

Authors:  J K Roche; S R Cook; E D Day
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

Review 3.  Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.

Authors:  James F Curtin; Gwendalyn D King; Marianela Candolfi; Remy B Greeno; Kurt M Kroeger; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.